Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
Cancer in the Asia-Pacific, a CRO Perspective(7/13/2017 )  (Premium)
Fast-tracking the Introduction of New Drugs(7/13/2017 )  (Premium)
Branded Generics in the Emerging Markets(7/12/2017 )  (Premium)
The Market
Chinese Retail Drug Sales Growth Flat in the First Half of 2017(7/14/2017 )  (Premium)
Industry News
CFDA Issues 2016 Annual Report for Biological Product Batch Release(7/14/2017 )  (Premium)
BGI Genomics Launches IPO on Chi-Next(7/14/2017 )  (Premium)
Qiagen's Chinese Translational Medicine JV Raises CNY 175M(7/12/2017 )  (free)
AstraZeneca Expands Australian Facility to Meet Growing Chinese Demands for Respiratory Medicines(7/12/2017 )  (Premium)
Performance of Most Domestically-listed Chinese Pharma Companies Continued to Grow in H1(7/12/2017 )  (Premium)
CDE Publicizes Batch 21 of Drug Applications To Be Granted Priority Review Status(7/11/2017 )  (Premium)
CFDA Approves Sanofi's Osteoarthritis Drug Synvisc-One(7/11/2017 )  (Premium)
HUYA Bioscience Establishes Strategic Partnership with Suzhou BioTOP(7/10/2017 )  (free)
General Health
NHFPC Issues Notice for Service Model Transformation of Pharmacy Affairs Management(7/13/2017 )  (Premium)
Product/R&D News
Snapshot of Domestically R&D and IND Filings of PD-1/PD-L1 New Drugs in China(7/14/2017 )  (Premium)
CDE-Accepted Drug Registration Applications Up in the First Half(7/12/2017 )  (Premium)
CFDA Approves BeyondSpring's Second Global Plinabulin Trial in China(7/10/2017 )  (Premium)
People in the News
Executive Movements(7/13/2017 )  (Premium)
CFDA Official Moves(7/13/2017 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links